1. Long term monitoring of penicillamine and myasthenia …

   Newsletter Article 31 January 2013 Pages: 1 - 1

2. … and carbamazepine-related pseudolymphoma

   Newsletter Article 31 January 2013 Pages: 1 - 1

3. Is trimethoprim the culprit in first dose reactions?

   Newsletter Article 31 January 2013 Pages: 1 - 1

4. Alternate day prednisone for cystic fibrosis has a high level of toxicity

   Newsletter Article 31 January 2013 Pages: 2 - 2

5. A strategy to tackle doxorubicin-induced cardiotoxicity is under development

   Newsletter Article 31 January 2013 Pages: 2 - 3

6. Alteplase

   Newsletter Article 31 January 2013 Pages: 3 - 3

7. Antineoplastics

   Newsletter Article 31 January 2013 Pages: 3 - 3

8. Aspirin

   Newsletter Article 31 January 2013 Pages: 3 - 3

9. Auranofin

   Newsletter Article 31 January 2013 Pages: 4 - 4

10. Buprenorphine

    Newsletter Article 31 January 2013 Pages: 4 - 4

11. Captopril

    Newsletter Article 31 January 2013 Pages: 4 - 4

12. Carbamazepine

    Newsletter Article 31 January 2013 Pages: 4 - 4

13. Carbidopa see Levodopa/carbidopa

    Newsletter Article 31 January 2013 Pages: 4 - 4

14. Carbidopa +; levodopa overdose

    Newsletter Article 31 January 2013 Pages: 4 - 4

15. Chlorhexidine overdose

    Newsletter Article 31 January 2013 Pages: 4 - 5

16. Corticosteroids

    Newsletter Article 31 January 2013 Pages: 5 - 5

17. Corticotrophin

    Newsletter Article 31 January 2013 Pages: 5 - 5

18. Doxorubicin

    Newsletter Article 31 January 2013 Pages: 5 - 5

19. Epinephrine

    Newsletter Article 31 January 2013 Pages: 5 - 5

20. Erythromycin

    Newsletter Article 31 January 2013 Pages: 5 - 5

21. Fluorouracil

    Newsletter Article 31 January 2013 Pages: 5 - 5

22. Fluoxetine

    Newsletter Article 31 January 2013 Pages: 5 - 5

23. Fluvoxamine see Tricyclic antidepressant interaction

    Newsletter Article 31 January 2013 Pages: 6 - 6

24. Ifosfamide

    Newsletter Article 31 January 2013 Pages: 6 - 6

25. Interleukin 2

    Newsletter Article 31 January 2013 Pages: 6 - 6

26. Iohexol

    Newsletter Article 31 January 2013 Pages: 6 - 6

27. Levodopa

    Newsletter Article 31 January 2013 Pages: 6 - 6

28. Levodopa see Carbidopa +; levodopa overdose

    Newsletter Article 31 January 2013 Pages: 6 - 6

29. Levodopa/carbidopa

    Newsletter Article 31 January 2013 Pages: 6 - 7

30. Lithium

    Newsletter Article 31 January 2013 Pages: 7 - 7

31. Meglumine metrizoate

    Newsletter Article 31 January 2013 Pages: 7 - 7

32. Methyldopa

    Newsletter Article 31 January 2013 Pages: 7 - 7

33. Mexiletine/nifedipine/nitroglycerin overdose

    Newsletter Article 31 January 2013 Pages: 7 - 7

34. Morphine

    Newsletter Article 31 January 2013 Pages: 7 - 7

35. Nifedipine see Mexiletine/nifedipine/nitroglycerin overdose

    Newsletter Article 31 January 2013 Pages: 7 - 7

36. Simvastatin

    Newsletter Article 31 January 2013 Pages: 7 - 8

37. Tegafur

    Newsletter Article 31 January 2013 Pages: 8 - 8

38. Tricyclic antidepressant interaction

    Newsletter Article 31 January 2013 Pages: 8 - 8

39. Tryptophan

    Newsletter Article 31 January 2013 Pages: 8 - 8

40. Tumour necrosis factor

    Newsletter Article 31 January 2013 Pages: 8 - 8

41. Valproic acid

    Newsletter Article 31 January 2013 Pages: 8 - 8

42. Zopiclone

    Newsletter Article 31 January 2013 Pages: 8 - 8